☰

Llewellyn Mills, PhD - Publications

Affiliations: 
2013-2016 School of Psychology University of Sydney, Camperdown, New South Wales, Australia 
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mills L, Lee JC, Boakes R, Colagiuri B. Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of Psychopharmacology (Oxford, England). 2698811221147152. PMID 36628993 DOI: 10.1177/02698811221147152  0.603
2020 Lintzeris N, Mills L, Dunlop A, Copeland J, Mcgregor I, Bruno R, Kirby A, Montebello M, Hall M, Jefferies M, Kevin R, Bhardwaj A. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence. 215: 108220. PMID 32768992 DOI: 10.1016/J.Drugalcdep.2020.108220  0.344
2020 Deacon RM, Mammen K, Holmes J, Dunlop A, Bruno R, Mills L, Graham R, Lintzeris N. Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations. Drug and Alcohol Review. PMID 32395850 DOI: 10.1111/Dar.13088  0.36
2020 Mills L, Lintzeris N, Bruno R, Montebello M, Dunlop A, Deacon RM, Copeland J, Jefferies M, Rivas C, Mammen K. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and Alcohol Review. 39: 356-364. PMID 32129558 DOI: 10.1111/Dar.13050  0.337
2019 Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Gugusheff J, Phung N, Montebello M, Chan T, Kirby A, Hall M, Jefferies M, Luksza J, et al. Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial. Jama Internal Medicine. PMID 31305874 DOI: 10.1001/Jamainternmed.2019.1993  0.336
2018 Mills L, Boakes RA, Colagiuri B. The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. Journal of Psychopharmacology (Oxford, England). 269881118817158. PMID 30526233 DOI: 10.1177/0269881118817158  0.603
2017 Mills L, Dar-Nimrod I, Colagiuri B. Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms. Scientific Reports. 7: 8407. PMID 28827535 DOI: 10.1038/S41598-017-08678-4  0.598
2016 Mills L, Boakes RA, Colagiuri B. Placebo caffeine reduces withdrawal in abstinent coffee drinkers. Journal of Psychopharmacology (Oxford, England). PMID 26933153 DOI: 10.1177/0269881116632374  0.624
Show low-probability matches.